Did you analyze how Bio-Rad Laboratories (BIO) fared in its international operations for the quarter ending December 2024? Given the widespread global presence of this maker of instruments used in ...
Longleaf Partners, managed by Southeastern Asset Management, released its “Partners Fund” third-quarter 2025 investor letter. The letter can be downloaded here. The fund returned -0.33% in the third ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Bio-Rad Laboratories ( (BIO)) has ...
Bio-Rad Laboratories (NYSE:BIO) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table provides a quick ...
Diagnostics company Bio-Rad has been sued by the California Institute of Technology for allegedly misusing the school's patented technology for analyzing biological samples. October 30, 2024 Bio-Rad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results